2277 irt manager jobs found

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. For more information on SMPA, visit our website https://www.us.sumitomo-pharma.com or follow us on LinkedIn. The IRT Manager serves as the business/process owner for Interactive Response Technology systems across SMPA oncology studies. This role leads the gathering of study User Requirements Specification and system configuration, User Acceptance Testing (UAT) and release, vendor governance, change control, and data integration/reconciliation. The manager ensures randomization, treatment assignment, and clinical-supply...